Results 291 to 300 of about 5,770,101 (353)

Advancements and challenges in personalized neoantigen-based cancer vaccines. [PDF]

Oncol Rev
Singh P, Khatib MN, R R, Kaur M, Srivastava M, Barwal A, Rajput GVS, Rajput P, Syed R, Sharma G, Kumar S, Shabil M, Pandey S, Brar M, Bushi G, Mehta R, Sah S, Goh KW, Satapathy P, Gaidhane AM, Samal SK.   +20 more
europepmc   +1 more source

Neo-antigen specific cancer vaccines for acute lymphoblastic leukemia-challenges, opportunities, and future directions. [PDF]

Cancer Immunol Immunother
Sandstad VBB, Modvig S, Holmström MO.
europepmc   +1 more source

Targeted Delivery of Personalized Cancer Vaccines Based on Antibody-Antigen Complexes. [PDF]

Vaccines (Basel)
Zhang Y, Yan L, Sun H, Zhang Z, Shen F, Sun L.   +5 more
europepmc   +1 more source

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines

Zitvogel L, Carrier A, Manghi P, Silva CAC, Lahmar I, Birebent R, Suissa D, Laheurte C, Schreibelt G, Lemant L, FAHRNER J, de Sousa E, Berthier F, Villemonteix J, Chevalier M, Piccinno G, Hocquet D, Lebhar I, Maeurer M, Caillat-Zucman S, Kroemer G, Derosa L, Launay O, Golden E, Bol K, De Vries IJM, Adotévi O, Segata N, Formenti S, Kobold S, Pieper D, Vital M, Santos-Peral A, Zaucha M, García-Bengoa M, Thorn-Seshold J, Stirling H, Rothenfusser S, Iebba V, Almonte A, Ajami N, White M, Sahasrabhojane P, Hoballah Y, Losh J, DePinho C, Dondossola E, Wargo J.   +47 more
europepmc   +1 more source

In Situ Cancer Vaccines: Redefining Immune Activation in the Tumor Microenvironment. [PDF]

ACS Biomater Sci Eng
Giram P, Md Mahabubur Rahman K, Aqel O, You Y.   +3 more
europepmc   +1 more source

Double-Blind Randomized Phase 2 Trial Testing Personal Cancer Vaccines in Patients with Advanced Ovarian Cancer. [PDF]

Vaccines (Basel)
Abaid LN, Corr BR, Eskander RN, Mason JR, Lopez KL, Godding K, Robles RM, Keirstead HS, Nistor GI, Dillman RO.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Therapeutic cancer vaccines

Nature Reviews Cancer, 2021
Therapeutic cancer vaccines have undergone a resurgence in the past decade. A better understanding of the breadth of tumour-associated antigens, the native immune response and development of novel technologies for antigen delivery has facilitated improved vaccine design.
Saxena, M., Burg, S.H. van der, Melief, C.J.M., Bhardwaj, N.   +3 more
semanticscholar   +6 more sources

CANCER VACCINES

Hematology/Oncology Clinics of North America, 2001
Attempts to generate an anticancer immune response in vivo in patients with cancer have taken several forms. Although to date there have been relatively few published studies describing the effects of the approach in hematologic malignancy, that circumstance is expected to change rapidly during the next few years. In solid tumors, it is not known which,
R F, Rousseau, C, Hirschmann-Jax, S, Takahashi, M K, Brenner   +3 more
  +7 more sources

Cancer vaccines

Seminars in Oncology Nursing, 2003
To provide a review of cancer vaccines, how they work, and the current state of the science underlying these treatments.Research studies, review articles, book chapters, personal communications.Vaccines have been studied in a variety of malignancies; however, melanoma has provided the best tumor model for vaccination.
Paula M, Muehlbauer, Douglas J, Schwartzentruber   +1 more
  +6 more sources

Cancer mRNA vaccines: clinical advances and future opportunities

Nature Reviews Clinical Oncology
E. Sayour, D. Boczkowski, Duane A. Mitchell, Smita K Nair   +3 more
semanticscholar   +3 more sources